Cytomegalovirus infection screening: Difference between revisions
No edit summary |
m (Bot: Removing from Primary care) |
||
(One intermediate revision by one other user not shown) | |||
Line 11: | Line 11: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Ophthalmology]] |
Latest revision as of 21:13, 29 July 2020
Cytomegalovirus infection Microchapters |
Differentiating Cytomegalovirus infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cytomegalovirus infection screening On the Web |
American Roentgen Ray Society Images of Cytomegalovirus infection screening |
Risk calculators and risk factors for Cytomegalovirus infection screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]
Overview
All donors and transplant candidates should be tested for CMV serology prior to transplantation in order to allow for risk stratification and guide prevention strategies.
Screening
All donors and transplant candidates should be tested for CMV serology prior to transplantation in order to allow for risk stratification and guide prevention strategies.